SARS-CoV-2 Envelope Protein (E Protein)

CAT.NOUNITPRICE
$145.00

Specifications


Description

The SARS-CoV-2 envelope protein (E Protein) is the smallest of the four main structural proteins and is abundantly expressed in host cells during the viral replication phase.  The E protein mediates viral assembly and packaging.  

Expression products available for SARS-CoV-2 E Protein:

  • E Protein Lentiviral Vector
  • E Protein Lentivirus
  • E Protein AAV Vector
  • E Protein AAV
  • E Protein Adenovirus
  • E Protein ORF Vector
  • E Protein Protein Vector
  • E Protein Recombinant Protein
SKUCOV006
Gene NameSARS-CoV-2 Envelope Protein (E Protein)
Insert Size

225bp

atgtactcat tcgtttcgga agagacaggt acgttaatag ttaatagcgt acttcttttt cttgctttcg tggtattctt gctagttaca ctagccatcc
ttactgcgct tcgattgtgt gcgtactgct gcaatattgt taacgtgagt cttgtaaaac cttcttttta cgtttactct cgtgttaaaa atctgaattc
ttctagagtt cctgatcttc tggtc

Accession NumberMT385497.1
SpeciesSARS-CoV-2
Documents


Supporting Protocol

    MSDS

      QC

        Other
        FAQs


        There are no FAQs for this product yet!
        References


        4
        • Wang, Q., Yu, H., Yu, H., Ma, M., Ma, Y., & Li, R. "miR‑223‑3p/TIAL1 interaction is involved in the mechanisms associated with the neuroprotective effects of dexmedetomidine on hippocampal neuronal cells in�vitro" Molecular Medicine Reports. : (2018). DOI: 10.3892/mmr.2018.9742.
        • Xu, T., He, B. S., Pan, B., Pan, Y. Q., Sun, H. L., Liu, X. X., ... & Wang, S. K. "MiR‐142‐3p functions as a tumor suppressor by targeting RAC1/PAK1 pathway in breast cancer" Journal of Cellular Physiology. : (2019).
        • Zhang, B., Roosmalen, I. A. M., Reis, C. R., Setroikromo, R., & Quax, W. J. "Death receptor 5 is activated by fucosylation in colon cancer cells" The FEBS Journal 286(3):555–571 (2019). DOI: 10.1111/febs.14742.
        • Zhao, Q., Zhao, S., Li, J., Zhang, H., Qian, C., Wang, H., … Zhao, Y. "TCF7L2 activated HOXA-AS2 decreased the glucocorticoid sensitivity in acute lymphoblastic leukemia through regulating HOXA3/EGFR/Ras/Raf/MEK/ERK pathway" Biomedicine & Pharmacotherapy 109:1640–1649 (2019). DOI: 10.1016/j.biopha.2018.10.046.